Literature DB >> 25805886

The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial.

David Kimhy1, Julia Vakhrusheva2, Matthew N Bartels3, Hilary F Armstrong4, Jacob S Ballon5, Samira Khan6, Rachel W Chang6, Marie C Hansen6, Lindsey Ayanruoh6, Amanda Lister6, Eero Castrén7, Edward E Smith5, Richard P Sloan5.   

Abstract

Individuals with schizophrenia display substantial neurocognitive deficits for which available treatments offer only limited benefits. Yet, findings from studies of animals, clinical and nonclinical populations have linked neurocognitive improvements to increases in aerobic fitness (AF) via aerobic exercise training (AE). Such improvements have been attributed to up-regulation of brain-derived neurotrophic factor (BDNF). However, the impact of AE on neurocognition, and the putative role of BDNF, have not been investigated in schizophrenia. Employing a proof-of-concept, single-blind, randomized clinical trial design, 33 individuals with schizophrenia were randomized to receive standard psychiatric treatment (n = 17; "treatment as usual"; TAU) or attend a 12-week AE program (n = 16) utilizing active-play video games (Xbox 360 Kinect) and traditional AE equipment. Participants completed assessments of AF (indexed by VO2 peak ml/kg/min), neurocognition (MATRICS Consensus Cognitive Battery), and serum-BDNF before and after and 12-week period. Twenty-six participants (79%) completed the study. At follow-up, the AE participants improved their AF by 18.0% vs a -0.5% decline in the TAU group (P = .002) and improved their neurocognition by 15.1% vs -2.0% decline in the TAU group (P = .031). Hierarchical multiple regression analyses indicated that enhancement in AF and increases in BDNF predicted 25.4% and 14.6% of the neurocognitive improvement variance, respectively. The results indicate AE is effective in enhancing neurocognitive functioning in people with schizophrenia and provide preliminary support for the impact of AE-related BDNF up-regulation on neurocognition in this population. Poor AF represents a modifiable risk factor for neurocognitive dysfunction in schizophrenia for which AE training offer a safe, nonstigmatizing, and side-effect-free intervention.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  aerobic fitness; brain-derived neurotrophic factor/active-play video games; cognition; neurotrophins

Mesh:

Substances:

Year:  2015        PMID: 25805886      PMCID: PMC4466187          DOI: 10.1093/schbul/sbv022

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  65 in total

1.  Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.

Authors:  Xiang Yang Zhang; Jun Liang; Da Chun Chen; Mei Hong Xiu; Fu De Yang; Therese A Kosten; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2012-01-26       Impact factor: 4.530

2.  Anticipating DSM-V: opportunities and challenges for cognition and psychosis.

Authors:  Deanna M Barch; Richard S E Keefe
Journal:  Schizophr Bull       Date:  2009-11-18       Impact factor: 9.306

Review 3.  The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.

Authors:  Eero Castrén; Tomi Rantamäki
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

4.  Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus.

Authors:  H van Praag; G Kempermann; F H Gage
Journal:  Nat Neurosci       Date:  1999-03       Impact factor: 24.884

5.  Running enhances neurogenesis, learning, and long-term potentiation in mice.

Authors:  H van Praag; B R Christie; T J Sejnowski; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 6.  Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials.

Authors:  Patrick J Smith; James A Blumenthal; Benson M Hoffman; Harris Cooper; Timothy A Strauman; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; Andrew Sherwood
Journal:  Psychosom Med       Date:  2010-03-11       Impact factor: 4.312

Review 7.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

8.  Hippocampal plasticity in response to exercise in schizophrenia.

Authors:  Frank-Gerald Pajonk; Thomas Wobrock; Oliver Gruber; Harald Scherk; Dorothea Berner; Inge Kaizl; Astrid Kierer; Stephanie Müller; Martin Oest; Tim Meyer; Martin Backens; Thomas Schneider-Axmann; Allen E Thornton; William G Honer; Peter Falkai
Journal:  Arch Gen Psychiatry       Date:  2010-02

Review 9.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

Review 10.  Thinking about the future cognitive remediation therapy--what works and could we do better?

Authors:  Til Wykes; Will D Spaulding
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

View more
  61 in total

Review 1.  The pro-cognitive mechanisms of physical exercise in people with schizophrenia.

Authors:  Joseph Firth; Jack Cotter; Rebekah Carney; Alison R Yung
Journal:  Br J Pharmacol       Date:  2017-04-20       Impact factor: 8.739

2.  Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function.

Authors:  Sophia Kogan; Luz H Ospina; David Kimhy
Journal:  Brain Behav Immun       Date:  2018-09-12       Impact factor: 7.217

3.  Effects of early trauma on psychosis development in clinical high-risk individuals and stability of trauma assessment across studies: a review.

Authors:  Samantha L Redman; Cheryl M Corcoran; David Kimhy; Dolores Malaspina
Journal:  Arch Psychol (Chic)       Date:  2017-12-18

Review 4.  Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-07-15       Impact factor: 3.911

5.  The Magic of Movement; the Potential of Exercise to Improve Cognition.

Authors:  Iris E Sommer; René S Kahn
Journal:  Schizophr Bull       Date:  2015-03-23       Impact factor: 9.306

Review 6.  On the Run for Hippocampal Plasticity.

Authors:  C'iana Cooper; Hyo Youl Moon; Henriette van Praag
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 7.  Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.

Authors:  Jason Smucny; Jason R Tregellas
Journal:  J Psychopharmacol       Date:  2017-04-26       Impact factor: 4.153

8.  A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study.

Authors:  Derek J Dean; Angela D Bryan; Raeana Newberry; Tina Gupta; Emily Carol; Vijay A Mittal
Journal:  J Clin Psychiatry       Date:  2017 Nov/Dec       Impact factor: 4.384

9.  What prevents youth at clinical high risk for psychosis from engaging in physical activity? An examination of the barriers to physical activity.

Authors:  Raeana E Newberry; Derek J Dean; Madison D Sayyah; Vijay A Mittal
Journal:  Schizophr Res       Date:  2018-06-13       Impact factor: 4.939

10.  Enhancing Cognitive Training Through Aerobic Exercise After a First Schizophrenia Episode: Theoretical Conception and Pilot Study.

Authors:  Keith H Nuechterlein; Joseph Ventura; Sarah C McEwen; Denise Gretchen-Doorly; Sophia Vinogradov; Kenneth L Subotnik
Journal:  Schizophr Bull       Date:  2016-07       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.